Period Ending | Jul 28, 2012 | Apr 28, 2012 | Jan 28, 2012 | Oct 29, 2011 |
---|
Total Revenue
|
2,343,000
|
2,541,000
|
2,189,000
|
2,181,000
| Cost of Revenue | 1,414,000 | 1,530,000 | 1,403,000 | 1,330,000 | |
Gross Profit
|
929,000
|
1,011,000
|
786,000
|
851,000
| |
|
Operating Expenses |
|
Research Development | 308,000 | 321,000 | 304,000 | 268,000 |
|
Selling General and Administrative | 255,000 | 281,000 | 303,000 | 222,000 |
|
Non Recurring | 44,000 |
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
322,000
|
409,000
|
179,000
|
361,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 5,000 | 1,000 | 4,000 | 9,000 |
|
Earnings Before Interest And Taxes | 327,000 | 410,000 | 183,000 | 367,000 |
|
Interest Expense | 25,000 | 23,000 | 24,000 | 24,000 |
|
Income Before Tax | 302,000 | 387,000 | 159,000 | 343,000 |
|
Income Tax Expense | 84,000 | 98,000 | 42,000 | (112,000) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 218,000 | 289,000 | 117,000 | 455,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
218,000
|
289,000
|
117,000
|
455,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
218,000
|
289,000
|
117,000
|
455,000
|
|